Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures
NCT00594945 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2014-07-01
Summary
Evaluate the safety and efficacy of intranasal Clonazepam in subjects with epilepsy.
Conditions
Interventions
- DRUG
-
Clonazepam
1 Dose
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Beverly Benson, PhD · Jazz Pharmaceuticals
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-12-31
- Primary Completion
- 2008-12-31
- Completion
- 2009-06-30
Countries
- United States
- Finland
Study Locations
More Related Trials
-
Clobazam Use in Epilepsia Partialis Continua - Pilot Study
NCT02134366 ·Status: TERMINATED ·Phase: PHASE3
-
TAK-935 Multiple Rising Dose Study in Healthy Participants
NCT02539134 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects
NCT02724423 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
NCT05067634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy
NCT01932502 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Diazepam on RNS Detections
NCT05273398 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures
NCT00655486 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
NCT05076617 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Pharmacodynamics of Nasal and Buccal Midazolam Using EEG
NCT01316445 ·Status: TERMINATED ·Phase: PHASE1
-
Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
NCT01118949 ·Status: COMPLETED ·Phase: PHASE2
-
Clobazam in Patients With Lennox-Gastaut Syndrome
NCT00518713 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
NCT05077904 ·Status: RECRUITING ·Phase: PHASE3
-
A Pilot Study of Topiramate in Childhood Absence Epilepsy
NCT00210574 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
NCT01118962 ·Status: COMPLETED ·Phase: PHASE2
-
Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy
NCT02726919 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy
NCT03179891 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy
NCT04857307 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability Study of Diazepam Buccal Film (DBF) in Subjects With Epilepsy
NCT03428360 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures
NCT00275925 ·Status: COMPLETED ·Phase: PHASE4
-
Buspirone Therapy for Localized Epilepsy
NCT01496612 ·Status: TERMINATED ·Phase: PHASE2
-
Use of Clobazam for Epilepsy and Anxiety
NCT03371836 ·Status: COMPLETED ·Phase: PHASE4
-
Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures
NCT06590896 ·Status: RECRUITING ·Phase: PHASE2
-
An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
NCT02564952 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1
NCT06961266 ·Status: TERMINATED ·Phase: PHASE1